BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21346693)

  • 21. Short- and Long-term Myocardial Infarction Survival Rate According to the Type of Drugs Prescribed at the Time of Discharge: A Study Using Iran National Registry Data.
    Mozaffarian S; Taherpour N; Sistanizad M; Aghaali M; Hashemi Nazari SS
    Arch Iran Med; 2022 Feb; 25(2):105-111. PubMed ID: 35429947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non ST-elevation myocardial infarction: New Zealand management guidelines.
    ;
    N Z Med J; 2005 Oct; 118(1223):U1680. PubMed ID: 16224504
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
    Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
    Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
    Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
    Pedrinelli R; Ciccone M; Novo S; Catapano AL
    G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes.
    Rockson SG; deGoma EM; Fonarow GC
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):375-88. PubMed ID: 17701334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editor's Choice- Gender difference in prognostic impact of in-hospital bleeding after myocardial infarction - data from the SWEDEHEART registry.
    Holm A; Sederholm Lawesson S; Swahn E; Alfredsson J
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):463-472. PubMed ID: 26450782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.
    Zaman MJ; Fleetcroft R; Bachmann M; Sarev T; Stirling S; Clark A; Myint PK
    Age Ageing; 2016 Jan; 45(1):96-103. PubMed ID: 26601697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
    Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
    Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital case volume and appropriate prescriptions at hospital discharge after acute myocardial infarction: a nationwide assessment.
    Schiele F; Capuano F; Loirat P; Desplanques-Leperre A; Derumeaux G; Thebaut JF; Gardel C; Grenier C
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):50-7. PubMed ID: 23233747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.